Success Metrics

Clinical Success Rate
25.0%

Based on 1 completed trials

Completion Rate
25%(1/4)
Active Trials
2(22%)
Results Posted
100%(1 trials)
Terminated
3(33%)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_4
1
11%
Ph phase_2
3
33%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
3(42.9%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

20.0%

1 of 5 finished

Non-Completion Rate

80.0%

4 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(1)
Terminated(4)
Other(1)

Detailed Status

Terminated3
Active, not recruiting1
Not yet recruiting1
Withdrawn1
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
25.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (42.9%)
Phase 41 (14.3%)
N/A3 (42.9%)

Trials by Status

active_not_recruiting111%
not_yet_recruiting111%
terminated333%
withdrawn111%
recruiting111%
unknown111%
completed111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9